- A chemogenetic approach to study the short chain fatty acid receptor FFA2
D. Bolognini, N. Barki, A. B. Tobin, G. Milligan. University of Glasgow, Glasgow, United Kingdom,
- Actions of ticagrelor on vascular smooth muscle cells
J. L. Hutchinson1, T. R. Forbes1, J. L. Johnson2, S. J. George2, S. J. Mundell1. 1Physiology, Pharmacology & Neuroscience, University of Bristol, Bristol, United Kingdom, 2Clinical Sciences, Bristol Heart Institute, Bristol, United Kingdom,
- A dopamine D1 receptor binding assay using bioluminescence resonance energy transfer (BRET) with Nanoluciferase
J. Appelhans1, A. J. Brown2, P. J. McCormick3. 1Queen Mary University of London, London, United Kingdom, 2GlaxoSmithKline, Stevenage, United Kingdom, 3William Harvey Research Institute, London, United Kingdom,
- Agonist activity of clozapine at muscarinic DREADD receptors
K. J. Thompson1, E. Khajehali2, C. Molloy1, S. J. Bradley1, A. Christopoulos2, A. B. Tobin1. 1Institute of Molecular, Cell and Systems Biology, Glasgow, United Kingdom, 2Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Parkville, Australia,
- Allosteric modulation of the orphan G-protein coupled receptor GPR84
Z. A. Mahmud, L. Jenkins, G. Milligan. University of Glasgow, University of Glasgow, Glasgow, United Kingdom,
- Analysis of inverse agonist activity of ticagrelor at the P2Y12 receptor
K. J. Olczak, R. Aungraheeta, J. L. Hutchinson, S. J. Mundell. School of Physiology, Pharmacology and Neuroscience, University of Bristol, Bristol, United Kingdom,
- Applying a ternary complex model to the pheromone pathway in yeast
H. Yamauchi1, W. Shaw2, T. Ellis3, G. Ladds1. 1Pharmacology, University of Cambridge, Cambridge, United Kingdom, 2Department of Bioengineering, Imperial College London, Cambridge, United Kingdom, 3Department of Bioengineering, Imperial College London, London, United Kingdom,
- Bqca, a highly specific M1 muscarinic receptor allosteric modulator, reduces native and misfolded prion protein in a prion-induced neurodegenerationmouse model
M. Rossi, C. Molloy, A. B. Tobin, S. J. Bradley. University of Glasgow, Glasgow, United Kingdom,
- BRET imaging of ligand interactions with the human ?2 adrenoceptor using novel ICI 118,551 based fluorescent antagonists
J. Goulding1,2, S. J. Mistry3,2, S. J. Briddon1,2, J. Woolard1,2, B. Kellam3,2, S. J. Hill1,2. 1Division of Physiology, Pharmacology and Neuroscience, School of Life Sciences, University of Nottingham, Nottingham, United Kingdom, 2Compare, University of Nottingham, Nottingham, United Kingdom, 3School of Pharmacy, University of Nottingham, Nottingham, United Kingdom,
- Characterisation of cancer cell response to CXCL8
E. Alassaf, A. Mueller. Pharmacy, University of East Anglia, Norwich, United Kingdom,